Pathology And Biomedical Solutions Inc Pacifica, CA - 94044

Pathology And Biomedical Solutions Inc is categorized under Services (Unclassified) in Pacifica, CA .

Pathology And Biomedical Solutions Inc was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.

If you are seeking more information, feel free to contact Jos J Otero at the company’s single location by writing to 215 Nataqua Avenue, Pacifica, California CA 94044 or by phoning (650) 392-4547. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Pathology And Biomedical Solutions Inc
Contact Person: Jos J Otero
Address: 215 Nataqua Avenue, Pacifica, California 94044
Phone Number: (650) 392-4547
Annual Revenue (USD): $100.000 to $499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Services (Unclassified)
SIC Code: 8999
NAICS Code: 541990
Share This Business:

Pathology And Biomedical Solutions Inc was started in 0 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Jos J Otero for inquiries that concern Pathology And Biomedical Solutions Inc by calling the company number (650) 392-4547, as your correspondence is most welcome. Additionally, the physical location of the single location of Pathology And Biomedical Solutions Inc can be found at the coordinates as well as the street address 215 Nataqua Avenue in Pacifica, California 94044.

For its online presence, you may visit Pathology And Biomedical Solutions Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.